Advertisement
Logos Biosystems
Logos Biosystems

The Scientist

» FDA, developmental biology and immunology

Most Recent

image: Molecular Fingerprint Predicts Flu Shot Response

Molecular Fingerprint Predicts Flu Shot Response

By | January 4, 2016

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Pregnancy May Explain Ebola Return

Pregnancy May Explain Ebola Return

By | December 21, 2015

Health officials suspect recently reported cases of the disease in Liberia might stem from a flare-up of the virus in a survivor who became pregnant.

0 Comments

image: Diagnostics Group Refutes FDA’s Concerns

Diagnostics Group Refutes FDA’s Concerns

By | December 17, 2015

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

0 Comments

image: Drug Produced in GM Chicken Approved

Drug Produced in GM Chicken Approved

By | December 10, 2015

The US Food and Drug Administration greenlights a rare-disease drug that is produced in the eggs of genetically modified chickens.

1 Comment

image: The Cyclopes of Idaho, 1950s

The Cyclopes of Idaho, 1950s

By | December 1, 2015

A rash of deformed lambs eventually led to the creation of a cancer-fighting agent.

0 Comments

image: Ebola’s Effects on the Eye

Ebola’s Effects on the Eye

By | November 30, 2015

A second doctor shows symptoms of ocular disease after recovering from Ebola infection.

0 Comments

image: Fatal Disease Drug in Limbo

Fatal Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

image: FDA OKs GM Salmon

FDA OKs GM Salmon

By | November 19, 2015

AquaBounty Technologies’s fast-growing fish is the first genetically modified animal approved by the US Food and Drug Administration.

0 Comments

Advertisement
BD Biosciences
BD Biosciences

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies